Charcot-Marie-Tooth Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
208
|
136
|
0.100 |
None |
1.000 |
17 |
3
|
2000 |
2019 |
Dejerine-Sottas Disease (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
176
|
45
|
0.780 |
None |
1.000 |
13 |
6
|
2000 |
2019 |
Charcot-Marie-Tooth disease type 4
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
14
|
77
|
0.110 |
None |
1.000 |
10 |
9
|
2001 |
2017 |
Peripheral demyelinating neuropathy
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
95
|
14
|
0.140 |
None |
1.000 |
9 |
1
|
2001 |
2019 |
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F
|
disease |
|
Disease or Syndrome
|
1
|
8
|
0.720 |
None |
1.000 |
5 |
8
|
2000 |
2012 |
Neuropathy
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
484
|
110
|
0.050 |
None |
1.000 |
5 |
2
|
2003 |
2016 |
Inherited neuropathies
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
104
|
4
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2016 |
Peripheral Nervous System Diseases
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
549
|
69
|
0.020 |
None |
1.000 |
2 |
|
2002 |
2017 |
Apathy
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
83
|
9
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Nonalcoholic Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
434
|
17
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Uveal melanoma
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
376
|
22
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Stomach Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3720
|
652
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Bone marrow toxicity
|
disease |
|
Disease or Syndrome
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Absence of sensation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
111
|
5
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Solid Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
1145
|
24
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Ischemic stroke
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1159
|
704
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
IMMUNE SUPPRESSION
|
phenotype |
|
Disease or Syndrome
|
222
|
3
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Lower Urinary Tract Symptoms
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
77
|
30
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Charcot-Marie-Tooth disease, Type 2B2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
5
|
1
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Muscle damage
|
phenotype |
|
Acquired Abnormality
|
163
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Peripheral neuropathy due to and following chemotherapy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
72
|
10
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adenomatous Polyposis Coli
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
609
|
237
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Demyelinating Diseases
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
156
|
5
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |